2-127569826-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001393586.1(MYO7B):c.508C>T(p.Leu170Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,613,344 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001393586.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7B | NM_001393586.1 | c.508C>T | p.Leu170Phe | missense_variant | 6/48 | ENST00000409816.8 | NP_001380515.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7B | ENST00000409816.8 | c.508C>T | p.Leu170Phe | missense_variant | 6/48 | 1 | NM_001393586.1 | ENSP00000386461.3 | ||
MYO7B | ENST00000428314.5 | c.508C>T | p.Leu170Phe | missense_variant | 6/47 | 5 | ENSP00000415090.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000805 AC: 2AN: 248536Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134888
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461166Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 726864
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2024 | The c.508C>T (p.L170F) alteration is located in exon 6 (coding exon 5) of the MYO7B gene. This alteration results from a C to T substitution at nucleotide position 508, causing the leucine (L) at amino acid position 170 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at